Dr. David A. Rigberg, MD

Dr. Rigberg practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Rigberg's NPI, 1285658500, was assigned on July 27, 2006. Dr. Rigberg graduated from College of Medicine - Tucson in 1994. Dr. Rigberg's California license number on file is A60026.

Dr. Rigberg's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Rigberg's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Rigberg is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Gonda (Goldschmied) Vascular Center. Dmand AI also links Dr. Rigberg to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rigberg practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Rigberg's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Rigberg is board certified in vascular surgery by the American Board of Surgery. Dr. Rigberg has a license on file in California.

Dmand AI lists arterial blot clot /embolism, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery, leg revascularization, peripheral vascular disease and varicose veins among the conditions Dr. Rigberg treats.

CMS data shows 372 Medicare services from Dr. Rigberg across 3 procedure codes in 2024, for 324 Medicare patients. Medicare paid $38,813 for them. Every service was in an office.

CMS counts 324 Medicare patients who saw Dr. Rigberg in 2024. The largest group is 75 to 84, with 142 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rigberg's median patient age at 69, with 51% women.

In 2024, Dr. Rigberg wrote 53 Medicare Part D claims for 27 patients. 70% of them were for generic drugs. CMS names the drug for 39 of them, across 2 drugs with 11 or more claims each, at $9,844 in total drug cost. In 2023, CMS named 29 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Rigberg for performance year 2024, reported as part of a group. Dr. Rigberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rigberg as offering telehealth. CMS counts 26 procedures of leg revascularization (restoring blood flow) by Dr. Rigberg, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Rigberg, published from 2009 to 2025. The most frequent topics are Esophageal Neoplasms, Tumor Cells, Cultured and Carcinoma, Squamous Cell. Dr. Rigberg has published most often in J Surg Res. Dr. Rigberg's most frequent co-authors are James D. Luketich, Kwame S. Amankwah, MD and Meena M. Archie, MD.

CMS Open Payments shows 201 general payments to Dr. Rigberg from 15 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 33% of the total. W. L. Gore & Associates, Inc. paid the most, $48,248.

Dmand AI lists 2 awards for Dr. Rigberg.

Dr. Rigberg graduated from College of Medicine - Tucson in 1994. Dr. Rigberg is a member of ACS and SVS.

Dr. Rigberg is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.